2.04 USD
+0.03 (+1.49%)
2.04 USD
0 (0%)
Taking everything into account, ONVO scores 2 out of 10 in our fundamental rating. ONVO was compared to 528 industry peers in the Biotechnology industry. The financial health of ONVO is average, but there are quite some concerns on its profitability. ONVO is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- ONVO had negative earnings in the past year.
- In the past year ONVO has reported a negative cash flow from operations.
- In the past 5 years ONVO always reported negative net income.
- ONVO had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- ONVO has a worse Return On Assets (-322.19%) than 94.71% of its industry peers.
- ONVO's Return On Equity of -3402.47% is on the low side compared to the rest of the industry. ONVO is outperformed by 85.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -322.19% | ||
| ROE | -3402.47% | ||
| ROIC | N/A |
ROA(3y)-116.81%
ROA(5y)-91.68%
ROE(3y)-185.97%
ROE(5y)-134.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for ONVO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- ONVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
- ONVO has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for ONVO has been increased compared to 5 years ago.
- There is no outstanding debt for ONVO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -137.52, we must say that ONVO is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of ONVO (-137.52) is worse than 97.18% of its industry peers.
- There is no outstanding debt for ONVO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -137.52 |
ROIC/WACCN/A
WACC10.04%
2.3 Liquidity
- ONVO has a Current Ratio of 0.72. This is a bad value and indicates that ONVO is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.72, ONVO is doing worse than 91.53% of the companies in the same industry.
- A Quick Ratio of 0.72 indicates that ONVO may have some problems paying its short term obligations.
- ONVO's Quick ratio of 0.72 is on the low side compared to the rest of the industry. ONVO is outperformed by 91.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 60.26% over the past year.
- ONVO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.20%.
- Measured over the past years, ONVO shows a very negative growth in Revenue. The Revenue has been decreasing by -48.77% on average per year.
EPS 1Y (TTM)60.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-473%
Revenue 1Y (TTM)-50.2%
Revenue growth 3YN/A
Revenue growth 5Y-48.77%
Sales Q2Q%380%
3.2 Future
- Based on estimates for the next years, ONVO will show a very strong growth in Earnings Per Share. The EPS will grow by 25.11% on average per year.
- ONVO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.71% yearly.
EPS Next Y96.31%
EPS Next 2Y40.15%
EPS Next 3Y25.11%
EPS Next 5YN/A
Revenue Next Year126.67%
Revenue Next 2Y63.71%
Revenue Next 3Y45.71%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ONVO. In the last year negative earnings were reported.
- Also next year ONVO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- ONVO's earnings are expected to grow with 25.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.15%
EPS Next 3Y25.11%
5. Dividend
5.1 Amount
- No dividends for ONVO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.04
+0.03 (+1.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-19 2025-02-19/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap3.47M
Revenue(TTM)122.00K
Net Income(TTM)-12.38M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.02%
Min EPS beat(2)10.83%
Max EPS beat(2)47.21%
EPS beat(4)4
Avg EPS beat(4)30.5%
Min EPS beat(4)10.83%
Max EPS beat(4)47.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-37.39%
Min Revenue beat(2)-46.52%
Max Revenue beat(2)-28.26%
Revenue beat(4)0
Avg Revenue beat(4)-38.8%
Min Revenue beat(4)-62.09%
Max Revenue beat(4)-18.3%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 28.43 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 9.53 | ||
| P/tB | 9.53 | ||
| EV/EBITDA | N/A |
EPS(TTM)-4.49
EYN/A
EPS(NY)-0.76
Fwd EYN/A
FCF(TTM)-5.95
FCFYN/A
OCF(TTM)-5.94
OCFYN/A
SpS0.07
BVpS0.21
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -322.19% | ||
| ROE | -3402.47% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-116.81%
ROA(5y)-91.68%
ROE(3y)-185.97%
ROE(5y)-134.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 4.71% | ||
| Cap/Sales | 10.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | -137.52 |
F-Score3
WACC10.04%
ROIC/WACCN/A
Cap/Depr(3y)148.6%
Cap/Depr(5y)294.16%
Cap/Sales(3y)57.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-473%
EPS Next Y96.31%
EPS Next 2Y40.15%
EPS Next 3Y25.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-50.2%
Revenue growth 3YN/A
Revenue growth 5Y-48.77%
Sales Q2Q%380%
Revenue Next Year126.67%
Revenue Next 2Y63.71%
Revenue Next 3Y45.71%
Revenue Next 5YN/A
EBIT growth 1Y36.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.51%
OCF growth 3YN/A
OCF growth 5YN/A
ORGANOVO HOLDINGS INC / ONVO FAQ
What is the ChartMill fundamental rating of ORGANOVO HOLDINGS INC (ONVO) stock?
ChartMill assigns a fundamental rating of 2 / 10 to ONVO.
What is the valuation status of ORGANOVO HOLDINGS INC (ONVO) stock?
ChartMill assigns a valuation rating of 1 / 10 to ORGANOVO HOLDINGS INC (ONVO). This can be considered as Overvalued.
How profitable is ORGANOVO HOLDINGS INC (ONVO) stock?
ORGANOVO HOLDINGS INC (ONVO) has a profitability rating of 0 / 10.
Can you provide the financial health for ONVO stock?
The financial health rating of ORGANOVO HOLDINGS INC (ONVO) is 4 / 10.